Clinical Trials Directory

Trials / Completed

CompletedNCT03276182

Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will compare cataract patients before and after phacoemulsification. Evaluations will be performed before and 1 and 3 months following cataract surgery, including parameters of dry eye syndrome and MGD. Dry eye syndrome parameters included TBUT, Schirmer's test type I, Oxford staining score, and the Ocular Surface Disease Index (OSDI) Questionnaire. MGD parameters consisted of lipid layer thickness (LLT), lid margin abnormality, meibum quality, meibum expressibility, MG orifice obstruction, MGD stage, and MG dropout.

Conditions

Interventions

TypeNameDescription
DEVICELipiview 2Tear film lipid layer thickness and meibomian gland dropout were measured by LipiView interferometer (TearScience Inc, Morrisville, NC)

Timeline

Start date
2015-10-05
Primary completion
2016-05-31
Completion
2016-05-31
First posted
2017-09-08
Last updated
2017-09-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03276182. Inclusion in this directory is not an endorsement.